Accession Number : ADA374126


Title :   Program for Critical Technologies in Breast Oncology


Descriptive Note : Final rept. 1 Jul 1994-30 Jun 1999


Corporate Author : YALE UNIV NEW HAVEN CT SCHOOL OF MEDICINE


Personal Author(s) : Costa, Jose ; Howe, Christine L


Full Text : https://apps.dtic.mil/dtic/tr/fulltext/u2/a374126.pdf


Report Date : Jul 1999


Pagination or Media Count : 148


Abstract : The Program for Critical Technologies in Breast Oncology is involved in several interrelated areas of support for research on breast cancer: (1) centralized collection and evaluation of human breast tissues; (2) establishment of a comprehensive database; (3) distribution of tissue samples; (4) molecular characterization of tissues; and (5) examination of ethical questions relating to tissue use. Human tissue samples are essential to progress in research on breast cancer. A shared resource facility can best cope with the demands of proper collection and storage of human tissue for a variety of research uses, without interfering with the pathologist's diagnosis. Because of advances in early detection of breast cancer, the size of tumors is getting smaller. This situation demands that efficient use be made of tissues, so that many researchers can share the use of one sample. Any research using tissues must be done with appropriate information about the tissues, and in a ethical manner that respects the patients' rights. The Program for Critical Technologies in Breast Oncology helps address all of these various issues, and provides one central facility where breast cancer researchers may obtain tissues and information about tissues, have access to research assays, and receive guidance on ethical issues.


Descriptors :   *TISSUES(BIOLOGY) , *MAMMARY GLANDS , *BREAST CANCER , DATA BASES , DETECTION , DISTRIBUTION , HUMANS , INTERACTIONS , FACILITIES , EFFICIENCY , SHARING , SAMPLING , DIAGNOSIS(GENERAL) , RESOURCES , HUMAN BODY , PATIENTS , CENTRALIZED , STORAGE , COLLECTION , PATHOLOGISTS


Subject Categories : Medicine and Medical Research


Distribution Statement : APPROVED FOR PUBLIC RELEASE